Observational studyEuropean journal of neurology2025

No Increase in Blood Pressure Assessed With the 24-h Holter Monitoring in Patients With Episodic Migraine During Early Treatment With Anti-CGRP Monoclonal Antibodies: A Prospective Observational Study (SAFHYPER).

Flavia Lo Castro et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.